 Primary objective: The primary objective of this study is to assess the effect of Ginkgo biloba L. leaf extract IDN 5933 in comparison to placebo in human subjects treated at therapeutic doses for 6 months on the level of DNA damage and genomic instability, measured with the Comet Assay and the Micronucleus assay, respectively . 